Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia
Clinical trial NCT03505372 · TERMINATED
Trial details
- NCT number
- NCT03505372
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2019-06-28
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.